Brett A. Giffin - Feb 20, 2023 Form 4/A - Amendment Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Commercial Officer
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Feb 20, 2023
Transactions value $
-$349
Form type
4/A - Amendment
Date filed
11/28/2023, 04:00 PM
Date Of Original Report
Mar 9, 2023
Previous filing
Nov 22, 2022
Next filing
Nov 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +1.33K +59.17% 3.59K Feb 20, 2023 Direct F1, F2
transaction TTOO Common Stock Sale -$349 -537 -14.97% $0.65 3.05K Feb 20, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -1.33K -33.32% $0.00 2.67K Feb 20, 2023 Common Stock 1.33K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The original Form 4 filed on March 9, 2023 is amended by this Form 4 amendment to correct the amount of securities beneficially owned following the reported transactions.
F3 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person adopted by the reporting person on November 10, 2021.
F4 On February 20, 2022 the reporting person was granted 4,000 RSU's that vest in three equal annual installments commencing on February 20, 2023.